Cartesian Therapeutics
RNAC
#8958
Rank
NZ$0.34 B
Marketcap
NZ$11.22
Share price
4.24%
Change (1 day)
-12.95%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2026 (TTM): NZ-$3.25

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.40. In 2021 the company made an earnings per share (EPS) of NZ-$13.16 an increase over its 2020 EPS that were of NZ-$37.84.

EPS history for Cartesian Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.25
2021NZ-$13.16-65.22%
2020NZ-$37.84-43.44%
2019NZ-$66.90-58.08%
2018NZ-$159.58-9.35%
2017NZ-$176.04-29.16%
2016NZ-$248.50